COR Cencora, Inc. Common Stock
Про Cencora, Inc. Common Stock Огляд компанії з Wikipedia
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Детальніше
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
Джерело: Wikipedia (Англійська), CC BY-SA 4.0 · Переглянути на Wikipedia ↗
COR Знімок акцій Ціна, ринкова капіталізація, P/E, EPS, ROE, борг/власний капітал, діапазон 52 тижнів
COR Графік ціни акцій Денні OHLCV з технічними індикаторами — панування, масштабування та налаштування вашого представлення
10-річна ефективність Тренди виручки, чистого прибутку, маржі та EPS
Оцінка Співвідношення P/E, P/S, P/B, EV/EBITDA — акція дорога чи дешева?
Прибутковість Валова, операційна та чиста маржа; ROE, ROA, ROIC
Фінансове здоровʼя Борг, ліквідність, платоспроможність — міцність балансу
Зростання Зростання виручки, EPS та чистого прибутку: рік до року, 3-річний CAGR, 5-річний CAGR
Ефективність капіталу Оборотність активів, оборотність запасів, оборотність дебіторської заборгованості
Дивіденди Дивідендна дохідність, коефіцієнт виплат, історія дивідендів, 5-річний CAGR
| Дата екс-дивіденду | Сума |
|---|---|
| 15 травня 2026 р. | $0,6000 |
| 13 лютого 2026 р. | $0,6000 |
| 14 листопада 2025 р. | $0,6000 |
| 15 серпня 2025 р. | $0,5500 |
| 16 травня 2025 р. | $0,5500 |
| 14 лютого 2025 р. | $0,5500 |
| 15 листопада 2024 р. | $0,5500 |
| 09 серпня 2024 р. | $0,5100 |
| 09 травня 2024 р. | $0,5100 |
| 08 лютого 2024 р. | $0,5100 |
| 10 листопада 2023 р. | $0,5100 |
| 10 серпня 2023 р. | $0,4850 |
| 11 травня 2023 р. | $0,4850 |
| 09 лютого 2023 р. | $0,4850 |
| 10 листопада 2022 р. | $0,4850 |
| 12 серпня 2022 р. | $0,4600 |
| 13 травня 2022 р. | $0,4600 |
| 11 лютого 2022 р. | $0,4600 |
| 01 грудня 2021 р. | $1,2700 |
| 12 листопада 2021 р. | $0,4600 |
COR Консенсус аналітиків Бичачі та ведмежі думки аналітиків, 12-місячна цільова ціна, потенціал зростання
- Активна купівля 5 25,0%
- Купівля 10 50,0%
- Утримувати 5 25,0%
- Продаж 0 0,0%
- Активний продаж 0 0,0%
12-місячна цільова ціна
12 аналітиків · 2026-08-13Історія прибутків EPS фактичний проти прогнозу, сюрприз %, коефіцієнт перевищення, дата наступного звіту про прибутки
| Період | EPS Actual | EPS прогноз | Сюрприз |
|---|---|---|---|
| 30 вересня 2026 р. | $4.48 | $4.39 | 0.09% |
| 30 червня 2026 р. | $4.48 | $4.39 | 0.09% |
| 31 березня 2026 р. | $4.75 | $4.86 | -0.11% |
| 31 грудня 2025 р. | $4.08 | $4.08 | 0.00% |
| 30 вересня 2025 р. | $3.84 | $3.82 | 0.02% |
| 30 червня 2025 р. | $4.00 | $3.88 | 0.12% |
| 31 березня 2025 р. | $4.42 | $4.15 | 0.27% |
Порівняння з аналогами (підгалузь GICS) Ключові показники порівняно з аналогами в секторі
| Тікер | Капіталізація | P/E | Виручка рік до року | Чиста маржа | ROE | Валова маржа |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Повні фундаментальні показники Усі показники за роками — звіт про прибутки та збитки, баланс, рух грошових коштів
Звіт про прибутки та збитки 15
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
Баланс 29
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
Грошовий потік 19
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
Прибутковість 8
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
Ліквідність та платоспроможність 4
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
Ефективність 3
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
Темпи зростання 8
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Оцінка (TTM) 16
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
Звіт про прибутки та збитки 15
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
Баланс 27
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
Грошовий потік 17
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
Прибутковість 8
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
Ліквідність та платоспроможність 4
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
Ефективність 3
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
Оцінка (TTM) 14
| Метрика | Тенденція | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
Фінансова звітність Звіт про прибутки та збитки, баланс, рух грошових коштів — річні, за останні 5 років
Звіт про прибутки та збитки
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Виручка | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| Валова маржа % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Операційна маржа % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| Чистий прибуток | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| Розбавлений EPS | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
Баланс
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Борг / Власний капітал | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| Поточний коефіцієнт | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Коефіцієнт швидкої ліквідності | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Грошовий потік
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| Вільний грошовий потік | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
Останні новини Останні заголовки, що згадують цю компанію
- IYK, MCK, CTVA, COR: ETF Outflow Alert
- Friday 5/29 Insider Buying Report: SCHW, COR
- Cencora (COR) виходить на лідерські позиції в галузі охорони здоров'я з міцними фундаментальними показниками та стратегічним переоцінюванням
- Основні моменти дзвінка Cencora щодо прибутків за 2 квартал
- Cencora Inc Q2 26 Дзвінок з конференції щодо прибутків 8:30 ранку за східним часом
- Що потрібно знати перед випуском звітності Cencora
Мої показники Ваш персональний список спостереження — вибрані рядки з Повних фундаментальних даних
Виберіть показники, які для вас важливі — натисніть ➕ поруч із будь-яким рядком у Повних фундаментальних даних вище.
Ваш вибір збережено і він буде застосовуватися до всіх тікерів.
Інституційні власники (13F) 1 490 подавачів звітності · $31.4B всього · Станом на 30 червня 2026 р.
Інституційні інвестори, які звітують про володіння цими акціями у своїй квартальній формі SEC 13F. Тільки довгі позиції; один подавець звітності може з'явитися двічі для окремих опціонних контрактів. Великі протилежні опціонні позиції (пут/кол) зазвичай відображають маркет-мейкінг або хеджування запасів, а не спрямованість переконань.
| Нові позиції | Закриті позиції | Збільшено | Зменшено | Зміна чистих акцій |
|---|---|---|---|---|
| 102 (-56 проти попереднього кв.) | 172 (+41 проти попереднього кв.) | 434 (-101 проти попереднього кв.) | 595 (+65 проти попереднього кв.) | +8.4M |
Порівняно з Q1 2026. Звіти SEC Form 13F подаються протягом 45 днів після закінчення кварталу плюс невеликий буфер для тих, хто подає із запізненням — квартали, що ще знаходяться в цьому вікні, пропускаються на користь останньої повністю звітної пари.
| Інституційний інвестор | Вартість | Акції | % від відстежуваного 13F | Тип |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3 502 993 290 | 12 378 943 | 11,14% | Акції |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 719 934 713 | 9 611 756 | 8,65% | Акції |
| STATE STREET CORP | $2 624 351 709 | 9 273 983 | 8,35% | Акції |
| Walgreens Boots Alliance, Inc. | $2 240 779 050 | 7 473 000 | 7,13% | Акції |
| GEODE CAPITAL MANAGEMENT, LLC | $1 358 112 555 | 4 819 419 | 4,32% | Акції |
| WELLINGTON MANAGEMENT GROUP LLP | $1 231 165 897 | 4 350 717 | 3,92% | Акції |
| FMR LLC | $850 228 724 | 3 004 554 | 2,70% | Акції |
| NORGES BANK | $700 042 999 | 2 473 825 | 2,23% | Акції |
| Capital Research Global Investors | $560 283 987 | 1 979 942 | 1,78% | Акції |
| Carmignac Gestion | $494 462 712 | 1 747 363 | 1,57% | Акції |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483 772 138 | 1 709 563 | 1,54% | Акції |
| Mawer Investment Management Ltd. | $421 312 792 | 1 488 843 | 1,34% | Акції |
| DIMENSIONAL FUND ADVISORS LP | $410 282 013 | 1 449 862 | 1,30% | Акції |
| CITADEL ADVISORS LLC | $347 541 038 | 1 228 147 | 1,11% | Акції |
| AMERICAN CENTURY COMPANIES INC | $338 738 459 | 1 197 038 | 1,08% | Акції |
| NEUBERGER BERMAN GROUP LLC | $315 929 430 | 1 116 828 | 1,00% | Акції |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313 668 332 | 1 108 447 | 1,00% | Акції |
| VANGUARD FIDUCIARY TRUST CO | $313 605 793 | 1 108 226 | 1,00% | Акції |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294 327 781 | 1 040 101 | 0,94% | Акції |
| Sumitomo Mitsui Trust Group, Inc. | $293 610 144 | 1 037 565 | 0,93% | Акції |
| MILLENNIUM MANAGEMENT LLC | $268 966 547 | 950 479 | 0,86% | Акції |
| LAZARD ASSET MANAGEMENT LLC | $261 088 180 | 922 638 | 0,83% | Акції |
| Caisse de depot et placement du Quebec | $258 709 937 | 914 234 | 0,82% | Акції |
| Boston Partners | $231 295 970 | 817 358 | 0,74% | Акції |
| National Pension Service | $208 758 025 | 737 713 | 0,66% | Акції |
| GOLDMAN SACHS GROUP INC | $208 660 680 | 737 369 | 0,66% | Акції |
| ALLIANCEBERNSTEIN L.P. | $205 281 694 | 653 472 | 0,65% | Акції |
| NORDEA INVESTMENT MANAGEMENT AB | $180 668 066 | 644 564 | 0,57% | Акції |
| Burgundy Asset Management Ltd. | $174 893 972 | 599 753 | 0,56% | Акції |
| Balyasny Asset Management L.P. | $172 225 024 | 608 612 | 0,55% | Акції |
| Point72 Asset Management, L.P. | $171 131 023 | 604 746 | 0,54% | Акції |
| Assenagon Asset Management S.A. | $166 084 924 | 586 914 | 0,53% | Акції |
| Squarepoint Ops LLC | $154 024 599 | 544 295 | 0,49% | Акції |
| Swiss National Bank | $147 506 155 | 521 260 | 0,47% | Акції |
| BNP PARIBAS FINANCIAL MARKETS | $141 101 751 | 498 628 | 0,45% | Акції |
| Swedbank AB | $134 859 213 | 476 568 | 0,43% | Акції |
| TimesSquare Capital Management, LLC | $132 589 070 | 422 070 | 0,42% | Акції |
| Legal & General Group Plc | $129 674 734 | 458 247 | 0,41% | Акції |
| RHUMBLINE ADVISERS | $123 138 883 | 435 151 | 0,39% | Акції |
| Vanguard Global Advisers, LLC | $120 449 305 | 425 646 | 0,38% | Акції |
| BlackRock, Inc. | $119 463 969 | 422 164 | 0,38% | Акції |
| ENVESTNET ASSET MANAGEMENT INC | $117 740 633 | 416 074 | 0,37% | Акції |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113 208 499 | 400 058 | 0,36% | Акції |
| California Public Employees Retirement System | $110 655 367 | 391 036 | 0,35% | Акції |
| BANK OF AMERICA CORP /DE/ | $105 342 134 | 372 260 | 0,33% | Акції |
| SEB Asset Management AB | $104 030 095 | 367 624 | 0,33% | Акції |
| VANGUARD ASSET MANAGEMENT, Ltd | $101 511 435 | 358 723 | 0,32% | Акції |
| VANGUARD GROUP INC | $100 694 421 | 298 133 | 0,32% | Акції |
| Walleye Capital LLC | $98 419 595 | 347 797 | 0,31% | Акції |
| MIZUHO MARKETS AMERICAS LLC | $96 213 200 | 340 000 | 0,31% | Акції |
| JOHNSON INVESTMENT COUNSEL INC | $93 893 214 | 331 802 | 0,30% | Акції |
| STOREBRAND ASSET MANAGEMENT AS | $93 049 484 | 328 820 | 0,30% | Акції |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88 657 847 | 282 224 | 0,28% | Акції |
| Cornerstone Investment Partners, LLC | $86 260 510 | 304 829 | 0,27% | Акції |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85 771 238 | 303 100 | 0,27% | Опціон кол |
| JONES FINANCIAL COMPANIES LLLP | $85 147 559 | 297 583 | 0,27% | Акції |
| CIBC Private Wealth Group LLC | $83 133 772 | 266 003 | 0,26% | Акції |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81 593 038 | 288 335 | 0,26% | Акції |
| FIL Ltd | $79 588 408 | 281 251 | 0,25% | Акції |
| LPL Financial LLC | $76 804 992 | 271 415 | 0,24% | Акції |
| TD Asset Management Inc | $76 770 210 | 271 292 | 0,24% | Акції |
| BANK OF MONTREAL /CAN/ | $70 057 359 | 247 570 | 0,22% | Акції |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69 812 864 | 246 706 | 0,22% | Акції |
| PRINCIPAL FINANCIAL GROUP INC | $68 792 155 | 243 099 | 0,22% | Акції |
| CITADEL ADVISORS LLC | $68 622 650 | 242 500 | 0,22% | Опціон кол |
| FIRST MANHATTAN CO. LLC. | $68 126 586 | 240 747 | 0,22% | Акції |
| AMERIPRISE FINANCIAL INC | $67 675 233 | 239 152 | 0,22% | Акції |
| TREMBLANT CAPITAL GROUP | $67 203 788 | 237 486 | 0,21% | Акції |
| RAYMOND JAMES FINANCIAL INC | $64 886 066 | 229 296 | 0,21% | Акції |
| EARNEST PARTNERS LLC | $63 127 461 | 223 081 | 0,20% | Акції |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60 624 220 | 214 235 | 0,19% | Акції |
| VICTORY CAPITAL MANAGEMENT INC | $60 395 855 | 213 428 | 0,19% | Акції |
| JENNISON ASSOCIATES LLC | $60 017 829 | 212 092 | 0,19% | Акції |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59 924 694 | 211 763 | 0,19% | Акції |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57 032 921 | 201 544 | 0,18% | Акції |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52 864 060 | 186 812 | 0,17% | Акції |
| BARCLAYS PLC | $51 304 557 | 181 301 | 0,16% | Акції |
| Mitsubishi UFJ Trust & Banking Corp | $51 082 984 | 180 518 | 0,16% | Акції |
| PFA Pension, Forsikringsaktieselskab | $50 217 651 | 177 460 | 0,16% | Акції |
| MARSHALL WACE, LLP | $50 044 447 | 176 848 | 0,16% | Акції |
| Susquehanna Portfolio Strategies, LLC | $49 878 621 | 176 262 | 0,16% | Акції |
| Sio Capital Management, LLC | $49 121 932 | 173 588 | 0,16% | Акції |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48 634 175 | 162 136 | 0,15% | Акції |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48 419 177 | 171 284 | 0,15% | Акції |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47 513 047 | 151 248 | 0,15% | Акції |
| AVIVA PLC | $47 242 096 | 166 945 | 0,15% | Акції |
| Jefferies Financial Group Inc. | $46 356 935 | 163 817 | 0,15% | Акції |
| Brandywine Global Investment Management, LLC | $45 181 831 | 133 773 | 0,14% | Акції |
| Asset Management One Co., Ltd. | $44 176 566 | 140 627 | 0,14% | Акції |
| Trajan Wealth LLC | $43 325 888 | 153 106 | 0,14% | Акції |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43 248 965 | 152 834 | 0,14% | Акції |
| Ensign Peak Advisors, Inc | $42 869 206 | 151 492 | 0,14% | Акції |
| CANADA PENSION PLAN INVESTMENT BOARD | $42 457 470 | 150 037 | 0,14% | Акції |
| UBS Group AG | $41 937 353 | 148 199 | 0,13% | Акції |
| Freestone Grove Partners LP | $41 195 379 | 145 577 | 0,13% | Акції |
| Qube Research & Technologies Ltd | $40 558 109 | 143 325 | 0,13% | Акції |
| VAN ECK ASSOCIATES CORP | $40 356 344 | 142 612 | 0,13% | Акції |
| MACKENZIE FINANCIAL CORP | $40 057 234 | 141 555 | 0,13% | Акції |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38 839 791 | 137 253 | 0,12% | Акції |
| ROYAL BANK OF CANADA | $37 959 000 | 134 139 | 0,12% | Акції |
Інсайдери компанії 49 інсайдерів · 23 керівники · 27 директори
| Інсайдер | Роль | Остання активність | Кількість акцій у власності | Купівлі за 12 міс. | Продажі за 12 міс. | Нетто 12 міс |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 18 червня 2025 р. M | 44 094 | 0 | 0 | $0 |
| David R Yost | CEO | 17 травня 2011 р. M | 1 530 341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 29 червня 2026 р. A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 09 листопада 2018 р. M | 53 505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 02 травня 2011 р. M | 89 698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 15 лютого 2007 р. A | 176 400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 30 червня 2026 р. A | 30 756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 30 червня 2026 р. A | 23 624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 16 вересня 2025 р. M | 305 913 | 0 | 2 | $-13 314 729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 29 травня 2025 р. S | 17 154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 28 червня 2024 р. A | 9 525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 31 травня 2024 р. S | 13 284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 20 грудня 2021 р. G | 81 367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 21 лютого 2020 р. M | 6 906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 23 травня 2019 р. S | 1 085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 04 квітня 2018 р. M | 47 989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 17 листопада 2017 р. F | 3 010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 09 листопада 2016 р. A | 34 195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 29 квітня 2016 р. F | 8 897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 13 листопада 2015 р. F | 5 224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 13 листопада 2015 р. M | 4 068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 01 лютого 2010 р. M | 27 190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 27 лютого 2008 р. A | 25 728 | 0 | 0 | $0 |
| Lauren M Tyler | Директор | 31 липня 2026 р. A | 4 456 | 1 | 0 | $148 626 |
| Dennis M Nally | Директор | 31 липня 2026 р. A | 13 188 | 0 | 0 | $0 |
| Ellen Cooper | Директор | 31 липня 2026 р. A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | Директор | 18 червня 2026 р. P | 31 767 | 2 | 0 | $2 161 800 |
| Lori Ryerkerk | Директор | 01 липня 2025 р. A | 516 | 0 | 0 | $0 |
| Werner Baumann | Директор | 01 травня 2025 р. A | 2 896 | 0 | 0 | $0 |
| Redonda Miller | Директор | 06 березня 2025 р. A | 3 194 | 0 | 0 | $0 |
| Frank Clyburn | Директор | 06 березня 2025 р. A | 1 157 | 0 | 0 | $0 |
| Lorence H. Kim | Директор | 06 березня 2025 р. A | 3 524 | 0 | 0 | $0 |
| Richard W Gochnauer | Директор | 11 березня 2024 р. M | 28 762 | 0 | 0 | $0 |
| Kathleen W Hyle | Директор | 11 березня 2024 р. M | 24 406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | Директор | 09 березня 2023 р. A | 20 479 | 0 | 0 | $0 |
| Jane E Henney MD | Директор | 05 березня 2023 р. M | 24 685 | 0 | 0 | $0 |
| Michael J Long | Директор | 05 березня 2023 р. M | 17 724 | 0 | 0 | $0 |
| Douglas R Conant | Директор | 04 березня 2019 р. M | 8 062 | 0 | 0 | $0 |
| Richard C Gozon | Директор | 29 лютого 2016 р. M | 51 484 | 0 | 0 | $0 |
| Edward E Hagenlocker | Директор | 02 березня 2015 р. M | 3 351 | 0 | 0 | $0 |
| Charles H Cotros | Директор | 07 грудня 2012 р. M | 26 773 | 0 | 0 | $0 |
| Lawrence J Wilson | Директор | 01 травня 2009 р. A | 35 942 | 0 | 0 | $0 |
| Rodney H Brady | Директор | 19 лютого 2007 р. A | 52 746 | 0 | 0 | $0 |
| James R Mellor | Директор | 03 січня 2006 р. M | 32 246 | 0 | 0 | $0 |
| Robert E Martini | Директор | 23 січня 2004 р. G | 1 602 739 | 0 | 0 | $0 |
| Francis G Rodgers | Директор | 03 листопада 2003 р. A | 7 918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | Власник 10% | 31 липня 2007 р. J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 11 березня 2026 р. M | 160 357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 05 березня 2026 р. A | 18 408 | 0 | 0 | $0 |
Інсайдери згідно з формами SEC 3/4/5; чистий результат = лише відкритий ринок купівлі/продажу
Активісти та власники %+ 5 3 холдинги
Інвестори, які подали Розклад SEC 13D — бенефіціарна власність понад 5% з наміром вплинути на емітента (активістські частки, кампанії в раді директорів, M&A). Кожен рядок показує останній відомий стан позиції цього подавця.
| Подавець | Подано | Частка | Статус | Мета | Подача |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 подання | 09 червня 2025 р. | 4,96% | Поправка | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 23 січня 2015 р. | — | Первинна подача | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 подання | 16 січня 2015 р. | — | Первинна подача | Кампанія в раді директорів | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Присутність в ETF Належить 212 ETF
Вага відображає лише прямі акціонерні володіння (N-PORT); фонди з кредитним плечем або похідними інструментами можуть мати додаткову експозицію за свопами, яка не відображається.
| Фонд | Вага | Одиниці | Станом на | Джерело |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3,11% | 1 841 NS | 30 квітня 2026 р. | N-PORT |
| IYK · iShares Trust | 2,76% | 121 004 SH | 08 серпня 2026 р. | Щоденно |
| FXG · First Trust Exchange-Traded AlphaDE… | 2,40% | 19 060 NS | 30 квітня 2026 р. | N-PORT |
| PAWZ · ProShares Trust | 2,36% | 2 847 NS | 31 травня 2026 р. | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2,34% | 1 750 NS | 31 травня 2026 р. | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,26% | 12 908 SH | 08 серпня 2026 р. | Щоденно |
| MEDI · Harbor ETF Trust | 2,16% | 1 935 NS | 30 квітня 2026 р. | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,91% | 186 NS | 30 квітня 2026 р. | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,83% | 568 607 SH | 08 серпня 2026 р. | Щоденно |
| SWP · Manager Directed Portfolios | 1,75% | 10 059 NS | 31 травня 2026 р. | N-PORT |
| IWP · iShares Trust | 1,73% | 1 079 322 SH | 08 серпня 2026 р. | Щоденно |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 42 128 SH | 08 серпня 2026 р. | Щоденно |
| QIDX · Spinnaker ETF Series | 1,66% | 2 065 NS | 30 квітня 2026 р. | N-PORT |
| EPMB · Harbor ETF Trust | 1,56% | 228 NS | 30 квітня 2026 р. | N-PORT |
| USMV · iShares Trust | 1,29% | 958 985 SH | 08 серпня 2026 р. | Щоденно |
| ESMV · iShares Trust | 1,27% | 308 SH | 08 серпня 2026 р. | Щоденно |
| UPSD · ETF Series Solutions | 1,21% | 3 966 NS | 30 квітня 2026 р. | N-PORT |
| SRHQ · Elevation Series Trust | 1,17% | 7 354 NS | 30 квітня 2026 р. | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,17% | 1 161 NS | 30 квітня 2026 р. | N-PORT |
| ACWV · iShares, Inc. | 1,17% | 120 628 SH | 08 серпня 2026 р. | Щоденно |
| FMAG · FIDELITY COVINGTON TRUST | 1,10% | 9 066 NS | 30 квітня 2026 р. | N-PORT |
| NULV · Nushares ETF Trust | 1,10% | 73 945 NS | 30 квітня 2026 р. | N-PORT |
| COWZ · Pacer Funds Trust | 1,03% | 608 442 NS | 30 квітня 2026 р. | N-PORT |
| QQWZ · Pacer Funds Trust | 1,02% | 1 555 NS | 30 квітня 2026 р. | N-PORT |
| GROZ · Zacks Trust | 0,93% | 3 136 NS | 31 травня 2026 р. | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,92% | 84 961 NS | 30 квітня 2026 р. | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,90% | 1 187 313 SH | 08 серпня 2026 р. | Щоденно |
| CURE · Direxion Shares ETF Trust | 0,86% | 3 879 NS | 30 квітня 2026 р. | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,85% | 45 117 SH | 08 серпня 2026 р. | Щоденно |
| IMCG · iShares Trust | 0,84% | 105 034 SH | 08 серпня 2026 р. | Щоденно |
| IXJ · iShares Trust | 0,80% | 102 068 SH | 08 серпня 2026 р. | Щоденно |
| ALTL · Pacer Funds Trust | 0,79% | 2 471 NS | 30 квітня 2026 р. | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 6 030 NS | 30 квітня 2026 р. | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,77% | 555 571 SH | 08 серпня 2026 р. | Щоденно |
| PALC · Pacer Funds Trust | 0,76% | 5 696 NS | 30 квітня 2026 р. | N-PORT |
| RXL · ProShares Trust | 0,76% | 2 029 NS | 31 травня 2026 р. | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,75% | 285 NS | 31 травня 2026 р. | N-PORT |
| ROE · EA Series Trust | 0,73% | 7 012 NS | 29 травня 2026 р. | N-PORT |
| TAX · EA Series Trust | 0,72% | 680 NS | 29 травня 2026 р. | N-PORT |
| LSEQ · Harbor ETF Trust | 0,68% | 342 NS | 30 квітня 2026 р. | N-PORT |
| DUHP · Dimensional ETF Trust | 0,68% | 249 048 NS | 30 квітня 2026 р. | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,66% | 3 314 NS | 31 травня 2026 р. | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 18 623 SH | 08 серпня 2026 р. | Щоденно |
| VO · VANGUARD INDEX FUNDS | 0,50% | 4 005 623 SH | 08 серпня 2026 р. | Щоденно |
| QARP · DBX ETF Trust | 0,49% | 1 374 NS | 29 травня 2026 р. | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,47% | 2 120 NS | 31 травня 2026 р. | N-PORT |
| RECS · Columbia ETF Trust I | 0,44% | 77 004 NS | 30 квітня 2026 р. | N-PORT |
| IWR · iShares Trust | 0,43% | 760 297 SH | 08 серпня 2026 р. | Щоденно |
| IMCB · iShares Trust | 0,43% | 22 227 SH | 08 серпня 2026 р. | Щоденно |
| JSTC · Tidal Trust I | 0,40% | 4 993 NS | 31 травня 2026 р. | N-PORT |